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Abstract
To promote transungual permeation of nystatin (NYST), molecule with high molecular
weight, no water-soluble, amphoteric by iontophoresis. The synergic effect of the
combination of cetylpyridinium chloride, CPC, or polyoxyethylene (20) sorbitan
monooleate, TW80, and iontophoresis was investigated. In vitro permeation experiments
were carried out through bovine hoof slices using vertical diffusion cells. A low current
density (0.2 mA/cm ) was applied by introducing Ag/AgCl electrodes in the donor (anode)
and receptor (cathode) chambers. The donor phase consisted of a solution, a suspension, or
gel-type vehicles containing NYST and surfactants in pH 5.6 HEPES buffer. The addition of
CPC to NYST suspension (SOSP) produced a fivefold increase on the permeability of the
bovine hoof membrane to the drug. The application of anodal iontophoresis further
improved NYST flux. Conversely, NYST transungual permeation was not influenced by
TW80 either in the passive diffusion or iontophoretic flux. Furthermore, the iontophoretic
treatment does not appear to induce irreversible alterations to the hoof bovine membranes.
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The present work demonstrated the efficacy of iontophoresis as a treatment for different nail
pathologies with large molecules very slightly soluble in water without irreversibly
affecting the nail structure. A synergistic effect between CPC and iontophoresis was
observed.
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INTRODUCTION
Delivery of drug through the nail continues to receive significant attention due to the need for
efficacious topical therapies for onychomycosis, common fungal infection of the nail. To date,
many formulations are commercially available for the onychomycosis topical therapy as
lacquers or solutions to apply on the nail but nonetheless, the problem of the low permeability
of the substrate following ungual administration is not completely solved. A good nail
penetration can be achieved by various methods: mechanical, chemical, and physical ( 1 ).
Abrasion and avulsion (mechanical method) have been investigated by several researchers and
can solve the problems although these were invasive techniques. These techniques allow
exposing the whole nail matrix to the subsequent chemical or surgical matrixectomy, healing
relapsing onychocryptosis, or supporting the treatment of long-term fungal infections of the nail.
Chemical methods include the use of chemicals that can temporarily alter the barrier properties
of the nail such as mercaptans/thiols (thioglycolic acid and 2-mercaptanethanol, N-acetyl-l-
cysteine), keratolytic agents (urea and salicylic acid), and organic solvent (ethanol, isopropanol,
propylene glycol, etc.). ( 2 – 4 )
Photodynamic therapy and lasers may represent alternatives in the future ( 5 ). A more recent
approach takes into account the hydration supported by occlusion to make nail matrix more
permeable and elastic by increasing pores size ( 1 ). Among the physical methods used in topical
field both for skin and nail treatments, the most common is the iontophoresis that consists in the
application of electric field to drive compounds through the skin or other body structures such
as the eye or nail. Iontophoresis acts on ionizable water-soluble products having positive or
negative charge on the basis of electrorepulsion theory. The mechanisms, linked to the transport
by iontophoresis, include electrophoresis (direct electrical field or Nernst-Planck effects) ( 6 ),
electroosmosis (convective solvent flux) ( 7 ), and electropermeabilization (alteration of the
membrane induced by the electrical field by improving its permeability) ( 8 , 9 ). Iontophoresis
has proved effective both for ionic and electroneutral molecules ( 10 , 11 ).
In the last years, different research papers demonstrated that iontophoresis significantly
facilitated drug penetration/permeation through the nail with the help of an electric field. In
particular, drug diffusion through the hydrated keratin of a nail may be improved by
iontophoresis. This technique was successfully applied to increase transungual permeation of
antifungal agents such as ciclopirox ( 3 ) and terbinafine, considered the most potent agents
against dermatophytes, for treating topically onychomycosis and other nail diseases ( 12 – 16 ).
Application of iontophoresis in in vitro and ex vivo experiments, after topical application, led to
a significantly higher drug diffusion into the nail bed with respect to passive diffusion. A
clinical study demonstrated that 40% of patients treated for 4 weeks with terbinafine and
iontophoresis (current density, 0.1 mA/cm ) showed an improvement in their health conditions
vs 11% of those treated with only the drug by passive diffusion. It was demonstrated that the
delivery of griseofulvin enhanced by eightfold with the help of iontophoresis, a success, since it
has a low solubility in water and lipophilic characteristics (log P 2.0) with a limited ability to
permeate into hydrophilic keratinous nail plate ( 17 ). A key role on increasing drug transungual
permeation by iontophoresis is played by different parameters such as type of electrode, current
density, co-ions, vehicle pH, charge, and drug concentration ( 3 , 11 , 18 , 19 ).
The aim of the present work was to find the optimal experimental conditions to promote
transungual permeation of nystatin (NYST), a tetraene diene polyene macrolide (Fig. 1 ),
applying iontophoresis. NYST was chosen as model of molecule with high molecular weight
(926.09 Da), very slightly soluble in water (≈ 0.03%) with a minimum at pH 7, corresponding to
the pI (isoelectric point), amphoteric with two ionizing groups, a carboxyl and an amino
function with ionization constants (pK ) estimated at 5.12 (pK ) and 8.89 (pK ) ( 20 ). Nystatin
possesses different hydrophilic and lipophilic moieties: the hydrophilic area is composed of
alcohols, carboxylic acid, and sugar whereas the lipophilic one consists of a chromophore of six
conjugated double bonds.
Fig. 1
Chemical structure of nystatin
The effect of the combination of cationic (cetylpyridinium chloride) or non-ionic surfactants
(polyoxyethylene (20) sorbitan monooleate) and iontophoresis on NYST transport through fully
hydrated bovine hoof membranes was investigated. Finally, the influence of the type of vehicle
(solution, suspension, or gel-type) on in vitro transungual permeation of nystatin, by applying
iontophoresis at low density current (0.2 mA/cm ), was determined.
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MATERIALS AND METHODS
Materials
The following materials were used: nystatin (NYST, Sigma, Germany), cetylpyridinium chloride
(CPC, Sigma, Italy), polyoxyethylene (20) sorbitan monooleate (Tween 80, TW80, Riedel-de
Haen), hydroxypropylcellulose (HPC, Klucel JF, Hercules), and HEPES buffer (AppliChem
GmbH, Germany). Methanol (MeOH, Carlo Erba, Italy), ethanol (Et, Carlo Erba, Italy), and
dimethylformamide (DMF, Fluka, Germany) were all HPLC-grade. All other chemical and
reagents used (sodium chloride, sodium hydroxide, sodium phosphate mono base monohydrate,
di-sodium hydrogen phosphate dried) were analytical grade. All the solutions were prepared
using high-purity deionized water (18 MΩ).
Formulations
The formulations under study (Table I ) were prepared in pH 5.6, 25 mM HEPES buffer, and
adjusted to a desired total ionic strength with sodium chloride providing a primary cationic
(Na ) and anionic (Cl ) charge carrier. The suspension of NYST (SOSP) was prepared by
introducing directly the drug in buffer solution; V1 and V2 formulations were prepared by
dissolving surfactants in buffer solution and then adding NYST. Cetylpyridinium chloride,
cationic surfactant, caused, in any case, the complete solubilization of the drug (micellar
solution), whereas TW80, non-ionic surfactant, produced a partial solubilization of NYST.
Table I
Composition of the Formulations Under Study
Formulations* NYST
(mg/ml)
CPC (%
w/w)
TW80 (%
w/w)
HPC (%
w/w)
EtOH (%
w/w)
NaCl
(mM)
SOSP 0.5 – – – – 50
V1 0.5 0.25 – – – 50
V2 0.5 – 0.125 – – 50
G1 0.5 0.25 – 4.0 – 50
G2 1.0 0.25 – 4.0 – 50
G3 0.5 0.25 – 4.0 – 10
G4 0.5 0.25 – 4.0 – 100
G1/Et 0.5 – – 4.0 10 50
*All formulations were prepared in pH 5.6, 25 mM HEPES buffer solution
G1–G4 gels were prepared by dissolving, at the first, CPC in HEPES buffer; then, appropriate
amounts of HPC were added at room temperature under continuous stirring for 12 h; and finally,
NYST was introduced in the dispersion. To prepare hydroalcoholic gels (G1/Et), HPC was
+ −
dispersed in HEPES buffer containing 10% w/w of ethanol following the same procedure
described above.
Measurement of viscosity was carried out on the semisolid formulations using HAAKE
RheoStress viscometer RS1 and sensor system C60/4 (Thermo Fisher Scientific SpA, Italy).
Tests were performed in triplicate at 32°C by applying increasing and decreasing values of the
shear rate to detect possible thixotropy of the systems. The rheological profiles were determined
with RheoWin Pro software. In all cases, pH of the formulations was 5.6.
NYST Delivery/Permeation Experiments
NYST In Vitro Permeation Through Bovine Hoof Membranes
In vitro permeation experiments were carried out through bovine hoof slices (thickness 90–
120 µm) obtained following the procedure previously described ( 21 ). Modified Gummer
vertical diffusion cells, consisted of donor and receiving chambers (respective volumes 2.0 and
5.8 ml) fastened together by a clamp, were used as apparatus. The hoof membranes, previously
hydrated by immersions in water for 15 h to reach equilibrium in terms of hydration before the
permeation tests, were placed between donor and receiving chambers, and the surface area
available for permeation was 1.23 cm . The effective thickness of the hydrated membranes
ranged between 90 and 120 µm.
To evaluate the influence of iontophoresis on transungual permeation of NYST, Ag/AgCl
electrodes, most commonly used because they are reversible and resistant to changes in pH,
were fixed in the donor and receptor chambers at a distance of 3 mm from the hoof membranes.
IOMED Phoresor II Dose Controller System was used to apply a constant direct current (DC).
The positively charged anode was introduced into donor chamber and the cathode into receptor
chamber (anodal iontophoresis). Current density of 0.2 mA/cm  was applied to stimulate NYST
penetration in the in vitro experiments. Two milliliters (for liquid vehicles) or 2 g (for semisolid
vehicles) of formulations (SOSP, V1, V2, G1–G4, and G1/Et) were placed in the donor
compartment. The receptor solution (catodal chamber) consisted of 25 mM HEPES buffer
pH 7.4 plus 154 mM NaCl, stirred at 600 rpm, and maintained at 32°C. The solubility of NYST
in the receiving phase at this temperature was 0.086 mg/ml. At predetermined intervals of time,
receiving phase was completely withdrawn and replaced with the same volume of fresh buffer to
ensure sink conditions. The amount of NYST permeated was determined by HPLC analysis.
Since NYST in pH 7.4 aqueous solutions rapidly underwent a phenomenon of degradation, the
samples of the receiving phase were immediately analyzed or maintained at − 20°C before the
analysis.
Two experimental protocols were used: protocol A consisted of passive permeation experiments
for 6 h (control) and protocol B consisted of iontophoretic treatment for 4 h applying constant
direct current of 0.2 mA/cm  (B1-1°period), followed by 2 h of passive permeation (B2-
2°period). In any case, the tests were replicated at least five times and the experiments were
performed completely in the dark.
Linear regression analysis of pseudo steady-state diffusion data allowed calculation of J, the
steady-state flux (given by Q/A·t, where Q is the amount of permeant diffusing across the area A
in time t) normalized to the thickness of the biological substrate and amount of drug permeated
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at the end of the permeation experiment.
NYST In Vitro Release Through Cellulose Acetate Membranes
In vitro release of NYST from the V1-G1-G1/Et formulations through cellulose acetate
membranes (SpectraPore3, MWCO3500, Spectrum®, NL) was investigated using vertical
Gummer cells ( 22 ) with an effective diffusion area of 1.23 cm . Five milliliters of 25 mM
HEPES buffer (pH 7.4) plus 154 mM NaCl, thermostated at 32°C and stirred at 600 rpm, were
used as the receptor medium. Two milliliters or 2 g of the formulations under study (donor
phase) were put in contact with the membrane. At predetermined time intervals, samples of the
receiving phase were withdrawn for analysis and replaced with an equal volume of fresh buffer
to maintain sink conditions. The amount of NYST released was determined by HPLC. Each
release test was replicated at least three times.
Analytical Method
Quantitative determination of NYST in the samples was carried out by HPLC. The apparatus
consisted of a Shimadzu LC-10AD system with an UV SPD-10AV detection and a software
Cromatoplus analyzer. The injection valve was a Rheodyne with a capacity of 20 µl. A
Phenomenex C18 analytical column (4.60 × 100 mm, Luna, 3 µ) was employed. The mobile
phase consisted of MeOH:water:DMF (60:30:10) mixture (flow rate 1.0 ml/min); the retention
time and the detection wavelength were 7.5 min and 305 nm, respectively. The limit of
determination and quantification were 6.9 and 2.0 ng/ml, respectively. The amount of drug in
each sample was determined from standard curves, obtained by plotting the concentration of
known solutions vs the corresponding peak areas of HPLC chromatograms.
Statistical Analysis
All data are the average of five determinations ± standard error (SE). Significant differences
between permeation parameters were assessed by GraphPad Prism software (GraphPad Software
Inc., San Diego, CA). The evaluation included the calculation of the means and standard errors
and group comparisons using Student’s two-tailed unpaired t test. Differences were considered
statistically significant at p < 0.05.
RESULTS
Table II  summarizes steady-state flux (µg cm  h ) of NYST for the different treatments and
the different formulations. The flux was calculated during passive permeation (protocol A),
iontophoretic treatment (protocol B1), and post-iontophoretic treatment (protocol B2).
Table II
Steady-State Flux of NYST Through Hoof Bovine Membranes Obtained from the Formulations Under Study
(mean ± S.E., n = 5)
Formulations
Flux (µg cm  h )
Protocol A Protocol B
2
−2 −1
−2 −1
Passive transport B1—iontophoretic transport B2—post-iontophoretic transport
SOSP 0.14 ± 0.011 0.63 ± 0.024* 0.40 ± 0.056
V1 0.76 ± 0.027 2.12 ± 0.079* 1.30 ± 0.057
V2 0.25 ± 0.024 0.45 ± 0.010 0.41 ± 0.003
G1 0.34 ± 0.020 2.08 ± 0.107* 1.26 ± 0.137
G2 0.45 ± 0.021 1.97 ± 0.491* 1.31 ± 0.379
G3 0.33 ± 0.022 1.63 ± 0.120* 1.06 ± 0.097
G4 0.36 ± 0.035 3.29 ± 0.180* 2.06 ± 0.135
G1/Et 0.31 ± 0.024 1.63 ± 0.116* 1.08 ± 0.089
*Significantly different from the passive transport (protocol A), p < 0.05
Significantly different from SOSP applying iontophoresis, p < 0.05
At first, this work was directed to understand the transungual kinetic of NYST from a
suspension: SOSP produced a flux of 0.14 ± 0.011 µg cm  h , during the passive permeation;
applying iontophoresis raised NYST transungual permeation up to ~ 4.5-fold (J = 0.63 ± 
0.024 µg cm  h ).
The addition of CPC to SOSP (V1) produced an increase (approximately fivefold) on the NYST
permeability of the bovine hoof membrane compared to that of the suspension. CPC promoted
the passive diffusion of NYST probably because of the solubilizing ability of the surfactant;
CPC was used at a concentration above CMC (0.04% w/w) and allowed a complete
solubilization of drug in pH 5.6 HEPES buffer solution; the application of anodal iontophoresis
(protocol B1) improved further NYST flux passing from 0.76 ± 0.027 to 2.12 ± 0.079 µg cm  h
 during 4 h of treatment (Table II ), indicating that the drug and the cationic surfactant did not
have a competitive mechanism.
On the contrary, NYST transungual permeation was not influenced by the presence of TW80:
there are no significant statistically differences either in the passive diffusion or iontophoretic
flux with respect to SOSP (J = 0.25 vs 0.14 µg cm  h  and J = 0.63 vs 0.45 µg cm  h
respectively). Furthermore, when TW80 was added to the formulation, the iontophoretic flux
increased from 0.25 to 0.45 µg cm  h ).
The differences among the vehicles under study are also well highlighted by the amount of drug
permeated at the end of the permeation studies using the different experimental protocols. When
the iontophoresis conditions were adopted, the amount of NYST permeated in presence of
cationic surfactant (V1) was remarkably higher than that when non-ionic surfactant was added
in the donor phase (V2) (Table III ).
Table III
Amount of NYST Permeated Through Hoof Bovine Membranes After 4 h (mean ± S.E., n = 5)
#
#
#
#
#
#
#
−2 −1
−2 −1
−2
−1
−2 −1 −2 −1
,
−2 −1
−2
Formulations
NYST permeated (µg cm )
Protocol A
Passive permeation
Protocol B1
Iontophoretic transport
SOSP 0.51 ± 0.038 2.50 ± 0.094*
V1 2.90 ± 0.128 7.94 ± 0.312*
V2 0.99 ± 0.069 1.68 ± 0.048
G1 1.61 ± 0.129 8.81 ± 0.441*
G2 2.11 ± 0.080 8.79 ± 1.150*
G3 1.55 ± 0.104 6.34 ± 0.499*
G4 1.67 ± 0.147 12.29 ± 0.698*
G1/Et 1.44 ± 0.042 6.74 ± 0.315*
*Significantly different from the passive transport (protocol A), p < 0.05
At this point, NYST was introduced in a hydrogel that can provide an electroconductive base
and make application easier as a hydrogel pad can adapt to the application site. The passive
diffusion flux of NYST through the bovine hoof membrane from the HPC hydrogel containing
CPC as a chemical enhancer (G1) was 0.34 ± 0.020 µg cm  h  about twofold lower than that
obtained by V1 (0.76 ± 0.027 µg cm  h ). All gels exhibited a Newtonian behavior, with linear
relationship between shear rate (D) and shear stress (tau). No thixotropy phenomenon was
observed and the viscosity of all gel-type formulations under study was in the range from 550 to
780 mPa·s. The increase in the vehicle viscosity reduced the diffusion rate of drug through the
gel matrix and consequently the transungual permeation. In fact, the release rate of NYST
through the cellulose acetate membrane was 2.57 ± 0.24 µg cm  h  for G1 against 25.31 ± 
1.73 µg cm  h  for V1; besides, after 6 h, NYST amount released from G1 was about nine
times less than that of V1 (18.68 ± 1.14 vs 165.58 ± 15.35 µg cm ).
The application of current (protocol B1) improved the flux of NYST from G1 (2.08 ± 
0.107 µg cm  h ) to reach that of V1 (2.12 ± 0.079 µg cm  h , protocol B1) probably due to
a best electroconductivity that partially counteracts the effect of the high viscosity on the
diffusion of the drug in the vehicle.
The effect of ionic strength on penetration was investigated by modifying NaCl concentration in
the donor solution (10, 50, or 100 mM) since the concentration of electrolytes may compete
with the drug ion. Increasing NaCl concentration from 10 to 100 mM in the donor phase
improved the drug permeation under effect of the application of the current from 1.63 ± 0.12 to
3.29 ± 0.18 µg cm  h; otherwise, no change of the passive diffusion was observed (Fig. 2 ). It is
evident that there was a direct relationship between ionic strength and permeation enhancement
with significant statistical differences, while a change in NYST concentration from 0.5 to
1.0 mg/ml (Table II ) did not affect the iontophoretic delivery of drug: the amount of NYST
permeated was 8.81 ± 0.44 and 8.79 ± 1.25 µg/cm  for 0.5- and 1.0-mg/ml formulations,
−2
−2 −1
−2 −1
−2 −1
−2 −1
−2
−2 −1 −2 −1
−2
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respectively. At higher drug concentration, the current is mainly carried by electrolytes that are
small, fast, and mobile molecules at the expense of NYST. The substitution of the surfactant
with ethanol (10%, G1/Et), as co-solvent/promoter to solubilize drug in the formulation,
appeared not to have a significant effect both on passive permeation of NYST and under
iontophoretic conditions. The 10% ethanol was not sufficient to solubilize the drug and, in any
case, played a negative role on dehydration of the bovine hoof membrane that contributes to
reduce the permeation. Although ethanol is an effective skin permeation enhancer, it does not
have a similar effect on the nail. Ethanol acts on the stratum corneum by altering intercellular
lipids; however, the lipid content of the nail comprises just 0.15–0.76% of its total weight ( 23 ).
Any increase in drug solubility engendered by adding an organic solvent to a formulation to
improve transungual drug delivery may be counteracted by the reduction in nail hydration and
permeability caused by the solvent itself. Smith et al. ( 24 ) studied the effect of organic solvents
EtOH, PPG, and PEG on the barrier properties of nail by demonstrating that permeant
partitioning into and transport across the nail were shown to decrease as the concentration of the
organic solvent in the binary solvent system increased.
Fig. 2
Effect of ionic strength on nystatin permeated through bovine hoof membrane for passive diffusion
and after iontophoretic treatment
The last part of the work was dedicated to understand whether the iontophoresis process caused
permanent damages to the tissue once the current supply was stopped.
Data, summarized in Table II , highlighted that, when the current was turned off (protocol B2),
NYST molecules persisted to permeate the membrane although the flux was decreasing after
stopping of iontophoresis. This could depend on either an alteration of the biological matrix or
the existence of a drug reservoir in the membrane. As example, Fig. 3  illustrates the transungual
permeation profiles of NYST from SOSP and V1 (CPC) formulations before and after stopping
of current.
Fig. 3
Permeation profiles of nystatin from SOSP and V1 formulations through bovine hoof membrane
stopping iontophoretic treatment after 4 h
DISCUSSION
This work was aimed at promoting transungual permeation of nystatin, an amphoteric
macromolecule, using the most suitable combination between chemical and physical methods.
Nystatin was chosen as model drug with high molecular weight (926.09 Da), which makes it
very difficult to pass through a barrier by passive diffusion, very slightly soluble in water, but
amphoteric with two ionizing groups. The search of a technique that increases transungual
permeation of this type of molecules would give a great scientific contribution to this field,
despite NYST was not easy to handle since it quickly undergoes a degradation phenomenon in
aqueous solution. The degradation depends on the pH of the aqueous solution: it is known ( 20 )
that nystatin is optimally stable in aqueous solution at pH from 5 to 7 (phosphate and citrate
buffer), when held at 37°C. In this work, the stability of drug in the formulations at pH 5.6 and
in the receiving phase at pH 7.4 for the time of the permeation experiments has been verified.
NYST in the formulations under study (pH = 5.6) remained completely stable during the tests
while NYST at pH 7.4 was stable in the first hour at all tested temperatures (4, 20, and 32°C).
On the contrary, after 6 h, drug recovery was 87, 82, and 76% at 4, 20, and 32°C, respectively.
To overcome this problem, the samples of the receiving phase just after withdrawal were
immediately analyzed or frozen at − 20°C.
As an enhancer, two surfactants, one cationic (CPC), and one non-ionic (TW80) were chosen,
first of all, to increase the drug solubility in the aqueous vehicle and, then, to study the role of
the charge on the iontophoretic process. Both CPC and TW80 were used above CMC but only
CPC (V1), that produced complete dissolution of the drug (micellar solution), demonstrated its
enhancement effect by increasing NYST passive diffusion through bovine hoof membranes
compared to that obtained by SOSP. On the other hand, TW80 appeared not to modify the NYST
transungual permeation and, moreover, not to help the solubilization of the drug in the
formulation; in fact, the addition of 0.125% TW80, to obtain vehicle V2, produced a small
increase in pH 5.6 HEPES buffer NYST solubility (from 0.05 to 0.07 mg/ml at room
temperature, for SOSP and V2 respectively), which was not further increased by doubling the
surfactant concentration; consequently, it did not positively affect either the solubilization
process or the interaction with the barrier. These data confirm the role of solubility in increasing
thermodynamic activity and the permeation of drug across biological membranes ( 13 , 25 ).
In addition, it could be assumed that the surfactant, in particular CPC, due to its amphoteric
nature and its cationic form, binds to the keratin, thus enabling NYST partially positively
charged at the pH 5.6 of the formulation to diffuse through the nail matrix and to reach the
receiving phase; the surfactant could improve transungual permeation entering in competition
with the antifungal agent in the form of an acid salt for binding to keratin of the various layers
of the nail that are negatively charged ( 26 ). Moreover, it has been reported that CPC included in
a topical nanoemulsion at 0.25% w/v for the treatment of onhycomycosis was able to diffuse
laterally from the nail edge across the nail bed and matrix and did not negatively influenced the
formulation tolerability in terms of skin irritation and any serious adverse events was noticed
( 27 , 28 ).
These formulations (SOSP, V1, and V2) were used, as donor phase, in the iontophoretic study.
HEPES buffer is chosen for its common use in iontophoresis research as it is zwitterionic at
pH 7.4 with a reduced ability of charge carrying. This aspect is crucial when you want to
discriminate the role of osmotic effect in relation to the ion concentrations because the
iontophoretic delivery of the drug will be reduced by these buffer ions as they will compete with
the drug for carrying the current noticed ( 29 ).
Moreover, HEPES buffer has been used to prevent the formation of a phosphate deposit on the
electrode and to improve the sensitivity of the analytical method for quantitative analysis of
NYST. The conditions of iontophoresis in term of current density (0.2 mA/cm ) and ionic
strength (donor phase, 50 mM; receiving phase, 154 mM) were chosen on the basis of literature
data ( 19 , 30 ). Nair et al. ( 14 ) demonstrated that transungual permeation of terbinafine (TBF)
was proportionally enhanced with an increase in applied current density from 0.1 to 1.0 mA/cm
as well as current duration (15, 30, 45, 60 min) but the amount of drug permeated, besides at
low current density (0.1 mA/cm ), was significantly higher than that in the MIC ( 14 , 31 ) and in
any case at 0.25-mA/cm  current density, TBF flux was increased of about 12 times.
During the present study, the ionic strength of receiver was maintained at 154 mM close the
physiological value as well as pH (7.4) ( 32 ) while for the donor phase, 50 mM was selected,
considering that an ionic strength of at least 50–100 was needed to have an optimal electric
current conduction across nails as found by Murthy et al. ( 10 ). To choose these conditions, it
has been taken into consideration that there is a critical concentration range over which the ionic
competition between drug and electrolytes negatively influences the current transport, mainly
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carried by electrolyte co-ion ( 10 ). On the contrary, the electrode chambers (in particular, at the
anode) must contain a definite amount of electrolyte to maintain the electrochemistry of the
Ag/AgCl couple.
About the pH, we chose pH 7.4 (physiological pH) for receiving phase and pH 5.6 for donor
phase. The pH of the donor phase was chosen taking into account that donor phase influences
the charge density on the biological barrier ( 11 ) and, since the keratin in the nail plate has an
isoelectric point (pI) of ~ 5, at pH 5.6, hoof bovine keratin membrane was negatively charged,
while NYST was partially positively charged. These pH conditions were chosen to promote
NYST anodal iontophoretic transport at pH above 5 compatible with the nail permselectivity
depending on pH. Nail contains a much lower lipid amount than the skin and it does not contain
follicles, important access for cutaneous iontophoresis. The hydrated nail is similar to a porous
hydrophilic hydrogel and its resistance to diffusion is provided by the keratin fibers suspended
in a continuous aqueous medium ( 14 , 33 ). NYST, with its positive charge, will be rejected by
positive electrode (anode) and anodal iontophoresis will be effective to promote NYST
transungual permeation.
In our study, the use of anodal iontophoresis increased the drug transungual transport already
when the suspension is used as a vehicle (SOSP), facilitating the permeation of the solubilized
and ionized drug fraction. The greatest contribution of iontophoretic technique to NYST
transungual permeation was obtained using the V1 formulation with CPC, suggesting that the
formation of cationic micelles with CPC could influence iontophoretic transport promoting the
interaction with negatively charged biological membranes.
When the current was applied in presence of V2 formulation containing TW80, there was an
increase of 1.8-fold in NYST flux (0.45 vs 0.25 µg cm  h) and in the amount of drug permeated
(0.99 vs 1.68). These values are lower than those obtained after iontophoretic treatment of SOSP
formulation even though without statistically significant differences. The surfactant seems to
have a shielding effect on the dissociated NYST in the experimental conditions chosen with a
lesser influence on the electric field.
The combination CPC/iontophoresis appears suitable to promote the transport NYST through
the ungual barrier. Increasing drug aqueous solubility seems critical in developing an efficient
transungual iontophoretic delivery system of poorly water-soluble molecules.
It is known that the nail under normal circumstances is a negatively charged, cation-
permselective membrane. Under the influence of an electric field, therefore, the transport of
cationic substances across the hydrated nail should be enhanced by anodal iontophoresis.
Moreover, a convective, electroosmotic flux proceeds in the anode-to-cathode direction,
supplementing cationic transport during iontophoresis and allowing the enhanced transport of
neutral polar substances above all in the case of anodal iontophoresis ( 34 ). It is known that
changes in ionic strength can modify ion distribution in the pores of the nail, besides when the
iontophoresis conditions were used.
In our paper, the effect of ionic strength was determined under “asymmetric conditions” as
reported by Smith et al. ( 32 ): the donor ionic strength was changed while the one of the receiver
was maintained at the physiological value in order to resemble in vivo conditions. A direct
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relationship between NYST transungual permeation and ionic strength was observed (Fig. 2 ),
suggesting a considerable contribution of the electroosmotic phenomenon, demonstrated also by
the irrelevance of an increase in drug concentration on producing any change in the flux values.
The last part of the work was dedicated to understand if the iontophoresis process caused
permanent damages to the tissue once the current supply was stopped.
The effect of iontophoresis on the tissue structure was studied performing the permeation
experiments from G4 formulation, where the effect of iontophoresis was more remarkable,
according to the following experimental protocol: the fully hydrated ungual substrate was pre-
treated with iontophoresis (anodal, current density:, 0.2 mA/cm ) for 4 h using pH 5.6 HEPES
buffer solution (100 mM) without drug, as donor phase; after this period, buffer solution was
replaced with G4 formulation, as donor phase, and the passive permeation was followed for 6 h
on the same bovine hoof membrane. At the same time, an experiment under the same
experimental conditions (pH 5.6 HEPES buffer solution, as donor phase, pre-treatment for 4 h,
then passive diffusion from G4 formulation for 6 h) was performed without application of
iontophoresis. No difference in the NYST permeation profile was observed comparing the
passive diffusion with and without iontophoretic pre-treatment, as well highlighted in Fig. 4 ; no
statistically significant difference between flux values (J = 0.33 ± 0.02 vs 0.29 ± 0.04 µg/cm  h,
respectively) and amount of NYST permeated (2.35 ± 0.15 vs 2.16 ± 0.11 µg/cm , respectively)
was demonstrated. Anyway, there is a little difference in the amount of NYST permeated in
these conditions with respect to the ordinary passive diffusion without 4-h pre-treatment period
(1.67 ± 0.147 vs 2.16 ± 0.11 µg/cm ), probably due to an increased membrane hydration for a
prolonged contact with the buffer solution, independent of the application of the electric field.
As reported by Hao et al. ( 3 ), it could be hypothesized a direct correlation between nail
resistance and concentration of the solutions in contact with the membranes. In any case, the
current application did not seem to modify the permeability of ungual membrane by suggesting
that the iontophoretic treatment does not provoke irreversible alterations to the hoof bovine
membranes.
Fig. 4
Transungual permeation profile of nystatin by passive diffusion with (circle) and without (square)
iontophoretic pre-treatment
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The two experiments performed for this goal appeared to suggest a reversible interaction
between the drug molecules and the keratin matrix of the bovine hoof that would then act as a
reservoir to release the drug over the time considering that no damage to the tissue has been
demonstrated by iontophoretic treatment. The role of iontophoresis on nail reservoir effect was
proposed also by other authors, for example, in the case of transungual permeation of
terbinafine ( 14 ).
CONCLUSIONS
The present work demonstrated that the iontophoretic technique could represent an effective
strategy for treatment of different pathologies of the nail promoting the transungual permeation
of large molecules with high molecular weight and very slightly soluble in water without
irreversibly affecting the nail structure. Indeed, the application of low current density
(0.2 mA/cm ) for a short period of time (4 h) could significantly enhance the drug transport
across the membranes creating a depot effect, which will contribute to a further release of the
drug when the electric field was switched off, reducing the need of frequent dosing. Moreover,
the presence of a cationic surfactant such as CPC showed a synergistic effect with the
iontophoretic procedure. The opportunity to exploit these conditions may contribute to improve
the efficacy of topical nail therapy, which is impaired by low permeation of drug molecules
across the highly keratinized nail plates.
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